Drugs on EMI
People in an extremely backward Haryana town, where almost every fifth person has hepatitis C, are forced to seek treatment on EMIs
Activists demand access to affordable oral hepatitis drugs
Giving patents to foreign-made medicines will add to patients’ woes, they urge
Hepatitis afflicts many HIV/AIDS patients, but there is no policy for them
Health ministry and AIDS control body keep shifting responsibility; no statistics available on patients with co-infection
World Hepatitis Day: Who can pay for hepatitis C treatment?
Selling price of HCV drugs far higher than production cost, all because of pro-industry patent regime
Maths of Gilead's hepatitis C drug
Why US firm's super expensive drug sofosbuvir costs so much and how it can be made at a tenth of current price
US authority approves more efficacious hepatitis C drug
Sofosbuvir's prohibitive cost will put it out of reach of most patients in developing countries, including India
24 die of jaundice in Maharashtra's textile city
Ichalkaranji does not have the facilities to care for the 3,500 persons taken ill by Hepatitis E
Most Central Asian countries have broken food safety control systems, finds paper
Severe food safety challenges in CAREC member countries; overlaps in mandates and institutional conflicts in China
Patent claim on hepatitis C drug questioned in many countries
With hepatitis C killing at least 700,000 people every year, civil society has strengthened efforts to make the drug accessible